Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMIGD3 | P0DMS9 | 5/20 | 0.77 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.77 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.77 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | CDK1 | P06493 | 4/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | CDK2 | P24941 | 2/20 | 0.60 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.60 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.60 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28068467 | 0.87 | TMIGD3 (0.77) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL27734468 | 0.87 | TMIGD3 (1.00) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL17933852 | 0.85 | ADORA2A (0.74) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL22571186 | 0.84 | TMIGD3 (0.81) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL4382069 | 0.81 | CDK1 (1.00) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL2049171 | 0.81 | RAB9A (1.00) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL27967736 | 0.81 | RAB9A (0.70) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL28740202 | 0.81 | RAB9A (0.78) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL27965570 | 0.81 | CDK1 (0.74) | TMIGD3ADORA2AADORA1RAB9AKMT2A | |
| SCHEMBL457250 | 0.81 | HTT (0.67) | TMIGD3ADORA2AADORA1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2613631-B1 | USE OF 6-SUBSTITUTED 9-HALOGENALKYL PURINES FOR REGULATION OF GROWTH AND DEVELOPMENT OF WHOLE PLANTS, PLANT CELLS AND PLANT ORGANS; NOVEL 6-SUBSTITUTED 9-HALOGENALKYL PURINES | Univerzita Palackého v Olomouci (CZ) | 2016-04-13 | — | — | EP | disclosed |
| US-9220269-B2 | Use of 6-substituted 9-halogenalkyl purines for regulation of growth and development of whole plants, plant cells and plant organs; novel 6-substituted 9-halogenalkyl purines | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2015-12-29 | — | — | US | disclosed |
| US-20130210632-A1 | USE OF 6- SUBSTITUTED 9 - HALOGENALKYL PURINES FOR REGULATION OF GROWTH AND DEVELOPMENT OF WHOLE PLANTS, PLANT CELLS AND PLANT ORGANS; NOVEL 6 - SUBSTITUTED 9 - HALOGENALKYL PURINES | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2013-08-15 | — | — | US | disclosed |
| EP-2613631-A1 | USE OF 6 - SUBSTITUTED 9 - HALOGENALKYL PURINES FOR REGULATION OF GROWTH AND DEVELOPMENT OF WHOLE PLANTS, PLANT CELLS AND PLANT ORGANS; NOVEL 6 - SUBSTITUTED 9 -HALOGENALKYL PURINES | Univerzita Palackého v Olomouci (CZ) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012031574-A1 | USE OF 6 - SUBSTITUTED 9 - HALOGENALKYL PURINES FOR REGULATION OF GROWTH AND DEVELOPMENT OF WHOLE PLANTS, PLANT CELLS AND PLANT ORGANS; NOVEL 6 - SUBSTITUTED 9 -HALOGENALKYL PURINES | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210632-A1 | USE OF 6- SUBSTITUTED 9 - HALOGENALKYL PURINES FOR REGULATION OF GROWTH AND DEVELOPMENT OF WHOLE PLANTS, PLANT CELLS AND PLANT ORGANS; NOVEL 6 - SUBSTITUTED 9 - HALOGENALKYL PURINES | PURB, METTL3, UMPS | TMIGD3 4081/4885ADORA2A 129/4885ADORA1 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.